Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 4545-year-old woman is evaluated in the intensive care unit for fever and hypotension. She was admitted 1212 days ago for induction chemotherapy for acute myeloid leukemia. Over the past 2424 hours, her temperature has spiked to 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), and her blood pressure has dropped to 85/50 mmHg85/50\text{ mmHg}, remaining hypotensive despite a 2 L2\text{ L} intravenous normal saline bolus. She has a central venous catheter in her right internal jugular vein. She currently complains of severe perianal pain. Physical examination reveals an indurated, exquisitely tender, and erythematous perianal region without fluctuance. Laboratory studies show an absolute neutrophil count of 100/μL100/\mu\text{L}. The patient's medical record documents a history of severe anaphylaxis (laryngeal edema and hypotension) to amoxicillin. Blood and perianal tissue cultures are obtained.

Which of the following intravenous pharmacologic agents should be included in this patient's empiric antimicrobial regimen? (Select all that apply)

  1. AztreonamCevap
  2. B
    Fluconazole
  3. MetronidazoleCevap
  4. D
    Piperacillin-tazobactam
  5. VancomycinCevap

Cevap

The correct interventions are Aztreonam, Metronidazole, and Vancomycin.
This patient presents with high-risk febrile neutropenia, septic shock, a central venous catheter, and a severe perianal infection, complicated by a history of penicillin anaphylaxis. Guidelines mandate immediate empiric antipseudomonal therapy. Due to her IgE-mediated penicillin allergy, beta-lactams like piperacillin-tazobactam or cefepime are contraindicated. Aztreonam is a monobactam that safely provides antipseudomonal coverage in penicillin-allergic patients. However, aztreonam lacks both Gram-positive and anaerobic activity. Vancomycin must be added to cover Gram-positive organisms (e.g., MRSA, Coagulase-negative Staphylococci) given her hemodynamic instability and central venous catheter. Furthermore, her perianal infection necessitates targeted anaerobic coverage, which is achieved by adding metronidazole.

Adım Adım Çözüm

1
Assess clinical stability, infectious risk, and allergy profile.
The patient has high-risk febrile neutropenia with septic shock, a severe penicillin allergy (anaphylaxis), a central line, and a perianal infection.
Identifying these exact parameters is necessary to select a broad-spectrum antibiotic regimen that safely avoids contraindicated drug classes while covering all likely pathogens.
2
Select appropriate Gram-negative and antipseudomonal coverage.
Aztreonam is selected.
Guidelines mandate immediate empiric antipseudomonal therapy. Because the patient has an IgE-mediated penicillin allergy, standard beta-lactams like piperacillin-tazobactam or cefepime are contraindicated. Aztreonam is a monobactam that lacks cross-reactivity with penicillins and provides excellent Gram-negative coverage.
3
Determine the need for specific Gram-positive coverage.
Vancomycin is added to the regimen.
Aztreonam has zero Gram-positive activity. Empiric MRSA and broad Gram-positive coverage with vancomycin is indicated for febrile neutropenia patients who are hemodynamically unstable (shock) or have a central venous catheter.
4
Determine the need for specific anaerobic coverage.
Metronidazole is added to the regimen.
The patient has a severe perianal infection, which strongly implicates gut anaerobes (e.g., Bacteroides species). Neither aztreonam nor vancomycin covers these anaerobes, making the addition of metronidazole necessary.

Anahtar Kavram

Empiric antimicrobial selection in high-risk febrile neutropenia requires synthesizing the patient's allergy profile, hemodynamic status, and site-specific infectious risks to ensure comprehensive coverage of Pseudomonas aeruginosa, MRSA, and anaerobes when specifically indicated.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru